Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. - Nery PB; Wells GA; Verma A; Joza J; Nair GM; Veenhuyzen G; Andrade J; Nault I; Wong JA; Sikkel M; Essebag V; Macle L; et al. (American heart journal, 2022)